Teoxane withdrew its $3.60 a share offer for Revance Therapeutics after Crown Labs raised its offer to $3.65. Revance ticked lower by 0.3% in premarket trading. Teoxane said that committed financing ...

Will those crazy kids manage to make it work? Unclear.

Geoffrey Zakarian's newsletter helped him build direct relationships with his audience, turning fans into customers.

Revenues at the business surged in the year to 31 May 2024 to £10.8m - higher than at the chocolate maker's peak - as new owner Paramount Retail Group focused on a turnaround ...